In conclusion, we propose that Dox-induced TrkAIII activation in NB cells resulting in pro-survival IP3-K/Akt signaling enhances the resistance to Dox cytotoxicity, and is inhibited by clinically approved lestaurtinib, entrectinib, and crizotinib inhibitors. Here, AKT1 is linked to neuroblastoma.